VASCULAR THERAPIES

VenoStent

This company develops bioabsorbable vascular wraps for chronic kidney disease patients to improve the durability and success of haemodialysis access sites.

ENDOVASCULAR DEVICES

This company develops minimally invasive vessel preparation tools to treat peripheral artery disease and failed arteriovenous fistulas for interventional clinicians.

Proteon Therapeutics

This company develops pharmaceuticals to improve blood flow and vascular access for patients with kidney and vascular diseases.

CuroTis

This biotechnology company develops regenerative grafts that stimulate the body to grow patient-specific blood vessels for individuals requiring vascular access or organ regeneration.

VascVersa Ltd

This company develops vascular cell therapies to regenerate blood vessels for patients with ischaemic diseases, chronic wounds, and retinal vascular conditions.

XS Innovations

This company develops implantable vascular access valves for patients with end-stage kidney disease to reduce complications during and between haemodialysis sessions.

R3 Vascular Inc.

This company develops bioresorbable sirolimus-coated vascular scaffolds for clinicians treating patients with peripheral arterial disease below the knee.

Access Vascular, Inc.

The company manufactures hydrophilic biomaterial catheters for hospitals and healthcare providers to reduce patient complications and improve vascular access outcomes.